203 related articles for article (PubMed ID: 28434976)
21. A Simple and Robust Method for Culturing Human-Induced Pluripotent Stem Cells in an Undifferentiated State Using Botulinum Hemagglutinin.
Kim MH; Matsubara Y; Fujinaga Y; Kino-Oka M
Biotechnol J; 2018 Feb; 13(2):. PubMed ID: 29027750
[TBL] [Abstract][Full Text] [Related]
22. A hybrid microfluidic system for regulation of neural differentiation in induced pluripotent stem cells.
Hesari Z; Soleimani M; Atyabi F; Sharifdini M; Nadri S; Warkiani ME; Zare M; Dinarvand R
J Biomed Mater Res A; 2016 Jun; 104(6):1534-43. PubMed ID: 26914600
[TBL] [Abstract][Full Text] [Related]
23. Production of homogenous size-controlled human induced pluripotent stem cell aggregates using ring-shaped culture vessel.
Torizal FG; Kim SM; Horiguchi I; Inamura K; Suzuki I; Morimura T; Nishikawa M; Sakai Y
J Tissue Eng Regen Med; 2022 Mar; 16(3):254-266. PubMed ID: 34923748
[TBL] [Abstract][Full Text] [Related]
24. Botulinum hemagglutinin-mediated in situ break-up of human induced pluripotent stem cell aggregates for high-density suspension culture.
Nath SC; Tokura T; Kim MH; Kino-Oka M
Biotechnol Bioeng; 2018 Apr; 115(4):910-920. PubMed ID: 29278408
[TBL] [Abstract][Full Text] [Related]
25. Microfluidic perfusion culture.
Hattori K; Sugiura S; Kanamori T
Methods Mol Biol; 2014; 1104():251-63. PubMed ID: 24297421
[TBL] [Abstract][Full Text] [Related]
26. SSEA-1-positive fibronectin is secreted by cells deviated from the undifferentiated state of human induced pluripotent stem cells.
Watanabe T; Saito S; Hiemori K; Kiyoi K; Mawaribuchi S; Haramoto Y; Tateno H
Biochem Biophys Res Commun; 2020 Aug; 529(3):575-581. PubMed ID: 32736676
[TBL] [Abstract][Full Text] [Related]
27. Microfluidic technology enhances the potential of human pluripotent stem cells.
Gagliano O; Elvassore N; Luni C
Biochem Biophys Res Commun; 2016 May; 473(3):683-7. PubMed ID: 26772885
[TBL] [Abstract][Full Text] [Related]
28. Differentiation of human pluripotent stem cells into highly functional classical brown adipocytes.
Nishio M; Saeki K
Methods Enzymol; 2014; 537():177-97. PubMed ID: 24480347
[TBL] [Abstract][Full Text] [Related]
29. Long-term maintenance of human induced pluripotent stem cells by automated cell culture system.
Konagaya S; Ando T; Yamauchi T; Suemori H; Iwata H
Sci Rep; 2015 Nov; 5():16647. PubMed ID: 26573336
[TBL] [Abstract][Full Text] [Related]
30. An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures.
Ting S; Chen A; Reuveny S; Oh S
Stem Cell Res; 2014 Sep; 13(2):202-13. PubMed ID: 25043964
[TBL] [Abstract][Full Text] [Related]
31. Optimizing Human Induced Pluripotent Stem Cell Expansion in Stirred-Suspension Culture.
Meng G; Liu S; Poon A; Rancourt DE
Stem Cells Dev; 2017 Dec; 26(24):1804-1817. PubMed ID: 29017378
[TBL] [Abstract][Full Text] [Related]
32. On chip purification of hiPSC-derived cardiomyocytes using a fishnet-like microstructure.
Li X; Yu L; Li J; Minami I; Nakajima M; Noda Y; Kotera H; Liu L; Chen Y
Biofabrication; 2016 Sep; 8(3):035017. PubMed ID: 27606680
[TBL] [Abstract][Full Text] [Related]
33. Elimination of cells deviated from human induced pluripotent stem cells with a photoactivatable IR700-labelled antibody.
Watanabe T; Tateno H
Biochem Biophys Res Commun; 2021 May; 554():13-18. PubMed ID: 33774274
[TBL] [Abstract][Full Text] [Related]
34. Single-cell cloning and expansion of human induced pluripotent stem cells by a microfluidic culture device.
Matsumura T; Tatsumi K; Noda Y; Nakanishi N; Okonogi A; Hirano K; Li L; Osumi T; Tada T; Kotera H
Biochem Biophys Res Commun; 2014 Oct; 453(1):131-7. PubMed ID: 25264198
[TBL] [Abstract][Full Text] [Related]
35. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
[TBL] [Abstract][Full Text] [Related]
36. Comparability of automated human induced pluripotent stem cell culture: a pilot study.
Archibald PR; Chandra A; Thomas D; Chose O; Massouridès E; Laâbi Y; Williams DJ
Bioprocess Biosyst Eng; 2016 Dec; 39(12):1847-1858. PubMed ID: 27503483
[TBL] [Abstract][Full Text] [Related]
37. Teratoma formation of human embryonic stem cells in three-dimensional perfusion culture bioreactors.
Stachelscheid H; Wulf-Goldenberg A; Eckert K; Jensen J; Edsbagge J; Björquist P; Rivero M; Strehl R; Jozefczuk J; Prigione A; Adjaye J; Urbaniak T; Bussmann P; Zeilinger K; Gerlach JC
J Tissue Eng Regen Med; 2013 Sep; 7(9):729-41. PubMed ID: 22438087
[TBL] [Abstract][Full Text] [Related]
38. Formation of well-defined embryoid bodies from dissociated human induced pluripotent stem cells using microfabricated cell-repellent microwell arrays.
Pettinato G; Wen X; Zhang N
Sci Rep; 2014 Dec; 4():7402. PubMed ID: 25492588
[TBL] [Abstract][Full Text] [Related]
39. Microfluidic perfusion modulates growth and motor neuron differentiation of stem cell aggregates.
Jackson-Holmes EL; Schaefer AW; McDevitt TC; Lu H
Analyst; 2020 Jul; 145(14):4815-4826. PubMed ID: 32515433
[TBL] [Abstract][Full Text] [Related]
40. Versatile, fully automated, microfluidic cell culture system.
Gómez-Sjöberg R; Leyrat AA; Pirone DM; Chen CS; Quake SR
Anal Chem; 2007 Nov; 79(22):8557-63. PubMed ID: 17953452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
